statistiche ricercatore

Continente	#
NA - Nord America	560
AS - Asia	396
EU - Europa	319
SA - Sud America	62
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	22
OC - Oceania	2
Totale	1.390

Nazione	#
US - Stati Uniti d'America	546
CN - Cina	187
IE - Irlanda	98
SG - Singapore	91
BR - Brasile	47
IT - Italia	44
DE - Germania	42
RU - Federazione Russa	37
FI - Finlandia	35
VN - Vietnam	35
HK - Hong Kong	31
FR - Francia	16
IN - India	16
ZA - Sudafrica	15
ES - Italia	9
GB - Regno Unito	9
JP - Giappone	8
BD - Bangladesh	7
PL - Polonia	6
CA - Canada	5
SE - Svezia	5
AR - Argentina	4
TR - Turchia	4
CL - Cile	3
CO - Colombia	3
IQ - Iraq	3
LT - Lituania	3
MA - Marocco	3
MX - Messico	3
AL - Albania	2
AU - Australia	2
BE - Belgio	2
BO - Bolivia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
NL - Olanda	2
PK - Pakistan	2
UY - Uruguay	2
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BN - Brunei Darussalam	1
CR - Costa Rica	1
ET - Etiopia	1
GE - Georgia	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
LV - Lettonia	1
NI - Nicaragua	1
PH - Filippine	1
PT - Portogallo	1
QA - Qatar	1
SA - Arabia Saudita	1
TN - Tunisia	1
UA - Ucraina	1
VC - Saint Vincent e Grenadine	1
VE - Venezuela	1
VG - Isole Vergini Britanniche	1
Totale	1.361

Nome	#
A patient with AL amyloidosis with negative free light chain results	134
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays	131
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis	123
Self-assembled monolayers of Prussian blue nanoparticles with photothermal effect	115
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis	114
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells	112
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis	109
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response	107
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome	98
A case of monoclonal gammopathy of renal significance	98
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: Prospective study in 206 patients	88
Clonal biomarkers for diagnosis and response to treatment assessment in light chain amyloidosis: The role of the laboratory	85
Unexplained Hyperthyrotropinemia: A Biochemical and Clinical Challenge	76
Totale	1.390

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	39	0	0	0	0	0	1	0	6	1	0	4	27
2022/2023	217	22	20	5	9	13	18	3	7	110	1	5	4
2023/2024	101	13	23	7	6	9	13	2	6	0	5	8	9
2024/2025	203	9	17	2	4	2	21	14	3	49	9	25	48
2025/2026	577	48	35	49	108	72	23	70	33	60	33	11	35
2026/2027	67	9	16	29	13	0	0	0	0	0	0	0	0
Totale													1.390